Evidence map›Paper›PMID 26184907›Full record

ReviewExpert review of anti-infective therapy2015

Bacillithiol: a key protective thiol in Staphylococcus aureus.

Varahenage R Perera, Gerald L Newton, Kit Pogliano

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of anti-infective therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. What Do We Know AboutToxics · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Antioxidants (Basel, Switzerland) · 2023
    Article
  12. Specific Features of the Proteomic Response of Thermophilic BacteriumInternational journal of molecular sciences · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Can thiol-based redox systems be utilized as parts for synthetic biology applications?Redox report : communications in free radical research · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Varahenage R PereraDivision of Biological Sciences, University of California at San Diego, 9500 Gilman Drive, Natural Sciences Building 4113, La Jolla, CA 92093-0377, USA.
Gerald L Newton
Kit Pogliano
University of California, San Diego · USSchlumberger (Ireland) · IE

Funding

The chemical and genetic basis of interspecies interactionsR01AI095125 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, POGLIANO, KIT J · 2011 to 2014
$2.4M
NIAID NIH HHS R01 AI095125NIAID NIH HHS R01-AI095125
6 · The paper itself

Abstract

Bacillithiol is a low-molecular-weight thiol analogous to glutathione and is found in several Firmicutes, including Staphylococcus aureus. Since its discovery in 2009, bacillithiol has been a topic of interest because it has been found to contribute to resistance during oxidative stress and detoxification of electrophiles, such as the antibiotic fosfomycin, in S. aureus. The rapid increase in resistance of methicillin-resistant Staphylococcus aureus (MRSA) to available therapeutic agents is a great health concern, and many research efforts are focused on identifying new drugs and targets to combat this organism. This review describes the discovery of bacillithiol, studies that have elucidated the physiological roles of this molecule in S. aureus and other Bacilli, and the contribution of bacillithiol to S. aureus fitness during pathogenesis. Additionally, the bacillithiol biosynthesis pathway is evaluated as a novel drug target that can be utilized in combination with existing therapies to treat S. aureus infections.

Indexed as

AnimalsAnti-Bacterial AgentsCysteineGlucosamineHumansMethicillin-Resistant Staphylococcus aureusPhylogenyStaphylococcal InfectionsStaphylococcus aureusSulfhydryl CompoundsAnti-Bacterial AgentsbacillithiolCysteineGlucosamineSulfhydryl Compoundsbacillithiolbacillithiol conjugate amidasedrug resistancefosfomycinoxidative stresspathogenesisStaphylococcus aureus

Identifiers

PMID26184907
PMCPMC4914364
OpenAlexW1610854354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.